Real world implementation of AlcoChange, a smartphone digital therapeutic to improve outcomes from alcohol-related liver disease: protocol for an individually randomised parallel group controlled trial

This trial will evaluate the real-world efficacy and cost-effectiveness of AlcoChange in reducing alcohol consumption and alcohol-related harm in individuals with ARLD. The study addresses the urgent need for scalable interventions to combat the rising burden of ARLD in the UK. The pragmatic design and mixed methods approach to implementation aim to enhance the generalizability and impact of the findings. The trial will provide valuable evidence to inform clinical practice and policy regarding the use of digital therapeutics for alcohol use disorder and liver disease.

Authors

Institutions

Publication Details

Journal
Trials
Published
2025-10-31
DOI
https://doi.org/10.1186/s13063-025-09005-3
Primary Topic
Alcohol Consumption and Health Effects
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Real world implementation of AlcoChange, a smartphone digital therapeutic to improve outcomes from alcohol-related liver disease: protocol for an individually randomised parallel group controlled trial

Zia Sadique, Jonathan Riddell Bamber, Sean Ewings, Lorraine McDonagh et al.
Trials
Alcohol Consumption and Health Effects
article

Real world implementation of AlcoChange, a smartphone digital therapeutic to improve outcomes from alcohol-related liver disease: protocol for an individually randomised parallel group controlled trial

Zia Sadique, Jonathan Riddell Bamber, Sean Ewings, Lorraine McDonagh, Linda C. Sobell, Elizabeth Dixon, Neil Rajoriya, Gautam Mehta, Fay Chinnery, Mark B. Sobell, Haqeeqat Gurm, Andrew Cook, Megan Lawrence, Ravan Boddu, Francesca Saffioti, Beth Stuart, Ravi Kumar, Richard Allen, Rajiv Jalan, Fran Webley
article en

Abstract

This trial will evaluate the real-world efficacy and cost-effectiveness of AlcoChange in reducing alcohol consumption and alcohol-related harm in individuals with ARLD. The study addresses the urgent need for scalable interventions to combat the rising burden of ARLD in the UK. The pragmatic design and mixed methods approach to implementation aim to enhance the generalizability and impact of the findings. The trial will provide valuable evidence to inform clinical practice and policy regarding the use of digital therapeutics for alcohol use disorder and liver disease.

TrialsVol. 26(1)
University Hospitals Birmingham NHS Foundation Trust (GB), Japan Patent Office (JP), Nova Southeastern University (US), John Radcliffe Hospital (GB), National Institute for Health and Care Research (GB), London School of Hygiene & Tropical Medicine (GB), Institut de Recherche en Santé Digestive (FR), NIHR Evaluation Trials and Studies Coordinating Centre (GB), University of Southampton (GB), University College London (GB)
National Institute for Health and Care Research, Invention for Innovation
Openalex Percentile: Top 55%
Alcohol Consumption and Health Effects
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.